Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
Completed
Conditions studied: Male Infertility
In brief
The purpose of this study is to determine if sperm DNA fragmentation is associated with in vitro fertilization (IVF) outcomes when euploid embryos are transferred.
Key facts
- Study ID
- NCT02268123
- Run by
- Reproductive Medicine Associates of New Jersey
- People needed
- 323
- Starts
- 2014-10-01
- Expected to finish
- 2018-07-01
- Last updated by the study team
- 2018-09-11
Who can join
Age: 35 and older, up to 40. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Completing first IVF/ICSI cycle at Reproductive Medicine Associates of New Jersey
- Couple undergoing CCS (Comprehensive Chromosome Screening)
- Female age 35-40 years
- Male will have to refrain from ejaculation no less than 2 days but no greater than 5 days prior semen specimen production on day of oocyte retrieval
You may not qualify if…
- Known genetic abnormality
- Use of sperm donation or cryopreserved sperm
- Use of Oocyte donation
- Use of gestational carrier
- Use of testicular aspiration or biopsy procedures to obtain sperm
- Presence of varicosele
- Presence of hydrosalpinges that communicate with endometrial cavity
- Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation
Where it is running
- Reproductive Medicine Associates of New Jersey — Basking Ridge, New Jersey, United States
- Reproductive Medicine Associates of Pennsylvania at LeHigh Valley — Allentown, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.